Annual Cash & Cash Equivalents
$138.13 M
-$46.87 M-25.34%
31 December 2023
Summary:
Sight Sciences annual cash & cash equivalents is currently $138.13 million, with the most recent change of -$46.87 million (-25.34%) on 31 December 2023. During the last 3 years, it has fallen by -$122.56 million (-47.01%). SGHT annual cash & cash equivalents is now -47.01% below its all-time high of $260.69 million, reached on 31 December 2021.SGHT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$118.56 M
+$387.00 K+0.33%
30 September 2024
Summary:
Sight Sciences quarterly cash and cash equivalents is currently $118.56 million, with the most recent change of +$387.00 thousand (+0.33%) on 30 September 2024. Over the past year, it has dropped by -$19.57 million (-14.16%). SGHT quarterly cash and cash equivalents is now -56.33% below its all-time high of $271.48 million, reached on 30 September 2021.SGHT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGHT Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -14.2% |
| 3 y3 years | -47.0% | -54.5% |
| 5 y5 years | +550.4% | - |
SGHT Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.0% | at low | -54.5% | +0.3% |
| 5 y | 5 years | -47.0% | +550.4% | -56.3% | +233.3% |
| alltime | all time | -47.0% | +3156.2% | -56.3% | +233.3% |
Sight Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $118.56 M(+0.3%) |
| June 2024 | - | $118.18 M(-7.2%) |
| Mar 2024 | - | $127.28 M(-7.9%) |
| Dec 2023 | $138.13 M(-25.3%) | $138.13 M(-4.4%) |
| Sept 2023 | - | $144.50 M(-6.5%) |
| June 2023 | - | $154.51 M(-7.7%) |
| Mar 2023 | - | $167.34 M(-9.5%) |
| Dec 2022 | $185.00 M | $185.00 M(-7.4%) |
| Sept 2022 | - | $199.82 M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $220.10 M(-7.7%) |
| Mar 2022 | - | $238.59 M(-8.5%) |
| Dec 2021 | $260.69 M(+323.8%) | $260.69 M(-4.0%) |
| Sept 2021 | - | $271.48 M(+663.2%) |
| June 2021 | - | $35.57 M(-26.4%) |
| Mar 2021 | - | $48.33 M(-21.4%) |
| Dec 2020 | $61.51 M(+189.6%) | - |
| Dec 2020 | - | $61.51 M |
| Dec 2019 | $21.24 M(+400.6%) | - |
| Dec 2018 | $4.24 M | - |
FAQ
- What is Sight Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sight Sciences?
- What is Sight Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sight Sciences?
- What is Sight Sciences quarterly cash and cash equivalents year-on-year change?
What is Sight Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of SGHT is $138.13 M
What is the all time high annual cash & cash equivalents for Sight Sciences?
Sight Sciences all-time high annual cash & cash equivalents is $260.69 M
What is Sight Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SGHT is $118.56 M
What is the all time high quarterly cash and cash equivalents for Sight Sciences?
Sight Sciences all-time high quarterly cash and cash equivalents is $271.48 M
What is Sight Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, SGHT quarterly cash and cash equivalents has changed by -$19.57 M (-14.16%)